The global Next-Generation Sequencing Market is entering a rapid structural expansion, driven by the convergence of artificial intelligence, high-throughput benchtop platforms, and rising demand for precision oncology, according to new research published by Stellar Market Research. Valued at USD 14.32 billion in 2025, the market is projected to reach USD 43.71 billion by 2034, expanding at a robust CAGR of 13.2% over the forecast period (2025–2034). Key Findings from the Report Market Valuation & Growth Trajectory: The global market expands from USD 14.32 billion in 2025 to USD 43.71 billion by 2034, reflecting a sustained CAGR of 13.2%. Technology Leadership: Targeted Sequencing and Resequencing maintained market dominance, proving essential as standard diagnostic workhorses for heme and solid tumor management. Fastest-Growing Technology: Whole Genome Sequencing (WGS) and Long-Read Sequencing (e.g., PacBio HiFi, Oxford Nanopore) are gaining rapid traction due to their enhanced capability to identify complex structural variants. Regional Dominance: North America leads the global landscape, supported by advanced clinical infrastructure, high genomic research funding, and favorable reimbursement policies in the United States. Emerging Regional Hub: Asia-Pacific represents the fastest-growing region, accelerated by national genomic initiatives such as GenomeIndia and China’s precision medicine programs. For further information, click the following link:https://www.stellarmr.com/report/req_sample/next-generation-sequencing-market/2661
Topics
